4//SEC Filing
LIPOSCIENCE INC 4
Accession 0001209191-13-055724
CIK 0001168197operating
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:22 PM ET
Size
8.9 KB
Accession
0001209191-13-055724
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
McDonald E. Duffy
Vice President, HR
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2013-12-04−12,731→ 0 totalExercise: $2.50Exp: 2013-12-12→ Common Stock (12,731 underlying) - Sale
Common Stock
2013-12-04$4.07/sh−12,731$51,774→ 3,765 total - Exercise/Conversion
Common Stock
2013-12-04$2.50/sh+12,731$31,828→ 16,496 total
Footnotes (2)
- [F1]Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $3.98 to $4.22 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The option vested over a period of four years, with 25% of the shares underlying the option vested on November 24, 2004, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001168197
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:22 PM ET
- Size
- 8.9 KB